Jamal Alsaeed

Publications

• Original Research Article   
  Therapeutic outcome of Differentiated Thyroid Carcinoma
  Author(s): Mohammed H. Alqambar*, Jamal Alsaeed, Abdulaziz Alwosabie, Njoud Alkaldi, Amal Abu alsaud, Zainab Alsaffar, Bashayer Aldossary, Gadeer Emsaad, Sahar Alradwan, Omar Amin, Mansour Alenezy, Mais Saradi and Fatima Kalifa
  
  Introduction: The majority of patients with Differentiated Thyroid Cancer (DTC) diagnosis have long-term survival, a considerable number may have a persistent or recurrent illness, and some may ultimately succumb to their thyroid cancer. The present study aimed to determine the disease-specific mortality and to identify the risk factors for recurrence. Material and Methods: This cohort research was conducted in the King Fahad Specialist Hospital in Dammam, Saudi Arabia. The electronic and paper files of all patients with a DTC diagnosis were reviewed. All 460 eligible individuals were risk-stratified using the 2015 American Thyroid Association. The Kaplan-Meier estimator was used to assess the Overall Survival (OS). Results: Out of 460 patients 369 (80.8%) were female. The median age 43.2 years (20 years-85 years). Patients were risk stratified using tumour node and metastasi.. Read More»
  

  Abstract HTML PDF